tm
Seeing Is Believing
tm
Seeing Is Believing
MXCT is currently covered by 3 analysts with an average price target of $8.59. This is a potential upside of $6.35 (283.48%) from yesterday's end of day stock price of $2.24.
MaxCyte's activity chart (see below) currently has 10 price targets and 15 ratings on display. The stock rating distribution of MXCT is 100% BUY.
Highest price target for MXCT is $9, Lowest price target is $9, average price target is $9.67.
Most recent stock forecast was given by DANIEL ARIAS from STIFEL on 12-Mar-2025. First documented stock forecast 24-Aug-2021.
Currently out of the existing stock ratings of MXCT, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$9
$6.8 (309.09%)
$11
3 months 4 days ago
(12-Mar-2025)
0/3 (0%)
$5.82 (183.02%)
Buy
$8
$5.8 (263.64%)
$7
1 years 3 months 3 days ago
(13-Mar-2024)
0/6 (0%)
$3.84 (92.31%)
Buy
$12
$7.98 (198.51%)
$12
1 years 8 months 12 days ago
(05-Oct-2023)
0/4 (0%)
$9.4 (361.54%)
What is MXCT (MaxCyte) average time for price targets to be met?
Which analyst has the current highest performing score on MXCT (MaxCyte) with a proven track record?
Which analyst has the current lower performing score on MXCT (MaxCyte) with a proven track record?
Which analyst has the most public recommendations on MXCT (MaxCyte)?
Which analyst is the currently most bullish on MXCT (MaxCyte)?
Which analyst is the currently most reserved on MXCT (MaxCyte)?
